DFTX NASDAQ
Definium Therapeutics, Inc.
1W: -5.4%
1M: -13.6%
3M: +15.2%
YTD: +46.8%
$20.59
+0.57 (+2.85%)
Weekly Expected Move ±7.8%
$18
$19
$21
$23
$24
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.2B
52W Range12.882-26.15
Volume1,676,075
Avg Volume2,525,520
Beta2.38
Dividend—
Analyst Ratings
Company Info
CEORobert Barrow
Employees74
SectorHealthcare
IndustryBiotechnology
IPO Date2016-11-15
Websitedefiniumtx.com
One World Trade Center
New York, NY 10007
US
New York, NY 10007
US
212 220 6633
About Definium Therapeutics, Inc.
Definium Therapeutics, Inc. is a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The companyâs lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Latest News
Definium (DFTX) Q1 2026 Earnings Transcript
-inc-logo-1200x675.jpg?v=20240515130629){kind=logo}
Q1 Earnings Estimate for DFTX Issued By HC Wainwright
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On?
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Karlin Daniel | S-Sale | 8,018 | $18.47 | 2026-03-25 |
| Sullivan Mark | S-Sale | 10,702 | $18.47 | 2026-03-25 |
| Barrow Robert | S-Sale | 24,431 | $18.47 | 2026-03-25 |
| Wiley Matthew T. | A-Award | 115,000 | — | 2026-02-03 |
| Roberts Brandi | A-Award | 150,000 | — | 2026-02-03 |